Back
Rhythm Pharmaceuticals Vs. Lindsay Industry Stock Comparison
Buy
85
RYTM
Rhythm Pharmaceuticals
Last Price:
41.06
Seasonality Move:
66.44%
Buy
57
LNN
Lindsay
Last Price:
122.89
Seasonality Move:
1.88%
Buy
85
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $41.06. The Score for RYTM is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
57
Lindsay (LNN)
is a Buy
Is Lindsay a Buy, Sell or Hold?
- The current Lindsay [LNN] share price is $122.88. The Score for LNN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- LNN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $41.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 52.11 | Buy |
| Chaikin Money Flow: | 396497 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.44 - 42.24) | Buy |
| Bollinger Bands (100): | (37.96 - 44.96) | Sell |
LNN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.06 | Buy |
| Relative Strength Index (14 RSI): | 59.21 | Buy |
| Chaikin Money Flow: | -419371 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (111.78 - 119.2) | Buy |
| Bollinger Bands (100): | (113.44 - 122.12) | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.28 | Sell |
| 20-day SMA: | 40.68 | Buy |
| 50-day SMA: | 39.68 | Buy |
| 200-day SMA: | 37.41 | Buy |
| 8-day EMA: | 41.12 | Sell |
| 20-day EMA: | 40.71 | Buy |
| 50-day EMA: | 40.3 | Buy |
| 200-day EMA: | 37.03 | Buy |
LNN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 117.05 | Buy |
| 20-day SMA: | 116.11 | Buy |
| 50-day SMA: | 116.63 | Buy |
| 200-day SMA: | 120.86 | Buy |
| 8-day EMA: | 118.73 | Buy |
| 20-day EMA: | 116.91 | Buy |
| 50-day EMA: | 116.77 | Buy |
| 200-day EMA: | 121.39 | Buy |
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.28 per share, a decrease this year of $1.36 per share, and an increase next year of $2.03 per share.
Lindsay Earnings Growth & LNN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.22 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.19 per share.
Rhythm Pharmaceuticals Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lindsay Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||